Remission induced by infliximab in a childhood polyarteritis nodosa refractory to conventional immunosuppression and rituximab

Joint Bone Spine. 2014 May;81(3):277-8. doi: 10.1016/j.jbspin.2013.11.009. Epub 2013 Dec 31.

Authors

Raquel Campanilho-Marques¹, Filipa Ramos², Helena Canhão³, João Eurico Fonseca³

Affiliations

¹ Rheumatology Department, Lisbon Academic Medical Centre, Portugal. Electronic address: raquelpcmarques@gmail.com.
² Rheumatology Department, Lisbon Academic Medical Centre, Portugal.
³ Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal.

PMID: 24388782
DOI: 10.1016/j.jbspin.2013.11.009

No abstract available

Keywords: Infliximab; Juvenile cutaneous polyarteritis nodosa; Juvenile polyarteritis nodosa; Remission; Rituximab.

Publication types

Case Reports
Letter

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Antibodies, Monoclonal / therapeutic use*
Antibodies, Monoclonal, Murine-Derived / therapeutic use
Child, Preschool
Humans
Immunosuppressive Agents / therapeutic use
Infliximab
Male
Polyarteritis Nodosa / drug therapy*
Remission Induction
Rituximab
Treatment Failure
Treatment Outcome

Substances

Anti-Inflammatory Agents, Non-Steroidal
Antibodies, Monoclonal
Antibodies, Monoclonal, Murine-Derived
Immunosuppressive Agents
Rituximab
Infliximab